This report presents the results of the tenth round of the external quality assessment (EQA-10) scheme for Listeria monocytogenes (L. monocytogenes) typing in EU/EEA and EU enlargement countries, organised for national public health reference laboratories (NPHRLs) providing data to the Food- and...

Infection with Salmonella spp. is the second most reported zoonotic disease in humans. In 2023,77 486 cases were reported in the European Union (EU). Salmonella is also associated with the highest number of foodborne outbreaks [2]. The overall EU trend in salmonellosis incidence between 2017 and...

ECDC organised this workshop to map training resources and identify needs in the area of communicable disease surveillance and control in EU candidate countries and potential candidates. Outcomes for participants included identifying priorities and drawing up country specific action plans, and...

This report describes the external quality assessment (EQA) scheme for the European Legionnaires' disease Surveillance network, for the detection, isolation, identification, and enumeration of Legionella species. The EQA schemes provide an outbreak scenario with packages of clinical and...

This technical report is a broad-brush picture of what we consider to be the main strengths and vulnerabilities of Ebola emergency preparedness in three EU Member States. It contains a brief background, a description of objectives and an explanation of the methodological approach. Findings are...

If the AIDS epidemic is to be brought to end by 2030, it is crucial to combat HIV-related stigma and discrimination in healthcare settings, as per United Nations (UN) Sustainable Development Goal 3 Target 3.3 [1] and the Paris Declaration [2]. The UNAIDS target related to stigma and...

In 2021, the Joint United Nations Programme on HIV/AIDS (UNAIDS) updated the HIV targets for 2025 as part of the global strategy to end AIDS by 2030. The updated targets are for 95% of all people living with HIV (PLHIV) to be diagnosed, 95% of those diagnosed to be on antiretroviral treatment...

This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is based on data collected between February and August 2023, for the period 2022. If countries do not have data for 2022, the latest available data is reported. This report is based on data...

In 2021 and 2022, a survey was developed to assess the impact of COVID-19 on HIV service delivery and monitoring capacity in Europe and Central Asia. Countries were asked whether COVID-19 had an impact on several HIV-specific and non-HIV specific services compared to pre-COVID levels. Although...

Pre-exposure prophylaxis (PrEP) is very effective at preventing HIV infection when taken as prescribed. It is an important element of the 'combination prevention' necessary to reach the United Nations (UN) Sustainable Development Goal of ending the AIDS epidemic by 2030 [3]. Since 2016, PrEP has...